Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Department of Health Promotion, National Institute of Public Health, Wako, Japan.
Gastroenterology. 2016 Nov;151(5):860-869.e7. doi: 10.1053/j.gastro.2016.07.040. Epub 2016 Aug 1.
BACKGROUND & AIMS: Some patients develop multiple squamous cell carcinomas (SCCs) in the upper aerodigestive tract, attributed to field cancerization; alcohol consumption has been associated with this process. We examined the association between multiple areas of dysplastic squamous epithelium with the development of SCC of the esophagus or head and neck cancer, as well as alcohol consumption and smoking.
We examined 331 patients with early stage esophageal SCC using Lugol chromoendoscopy to evaluate the dysplastic squamous epithelium in the esophagus. Patients then were assigned to 3 groups, based on the number of Lugol-voiding lesions: A, no lesion; B, 1-9 lesions; or C, 10 or more lesions. Participants completed lifestyle surveys on their history of drinking, smoking, and diet. All participants were evaluated by laryngopharyngoscopy before registration; only those without head and neck cancer were included, except for patients with superficial SCC limited to the subepithelial layer. Lesions detected in the esophagus and head and neck by surveillance were considered to be metachronous. The study end point was the cumulative incidence of metachronous SCCs in the esophagus and head and neck after endoscopic resection of esophageal SCC, according to the grade of Lugol-voiding lesions. At study entry, all patients were instructed to abstain from alcohol and smoking.
Over the 2-year study period, metachronous SCCs of the esophagus were detected in 4% of patients in group A, in 9.4% of patients in group B, and in 24.7% of patients in group C (P < .0001 for patients in group A vs B or B vs C). Head and neck SCCs were detected in none of the patients in group A, in 1.7% of the patients in group B, and in 8.6% of the patients in group C (P = .016 for patients in group A vs C and P = .008 for patients in group B vs C). SCC of the esophagus or head and neck developed in 4.0% of patients in group A, in 10.0% of patients in group B, and in 31.4% of patients in group C (P < .0001 for group A vs B or A vs C). Alcohol abstinence decreased the risk of multiple SCCs of the esophagus (adjusted hazard ratio, 0.47, 95% confidence interval, 0.25-0.91; P = .025), whereas smoking abstinence did not.
Multiple dysplastic lesions in the esophagus increase the risk of multiple SCCs. Alcohol abstinence reduces the risk of metachronous SCCs. Clinical Trials registry: UMIN000001676 and UMIN000005466.
一些患者在上呼吸道消化道中出现多个鳞状细胞癌(SCC),归因于癌前病变;饮酒与这一过程有关。我们研究了多个发育不良的鳞状上皮区域与食管或头颈部癌症 SCC 的发展之间的关系,以及饮酒和吸烟的关系。
我们使用卢戈氏染色内镜检查了 331 例早期食管 SCC 患者,以评估食管内发育不良的鳞状上皮。然后,根据卢戈氏染色缺失病变的数量,将患者分为 3 组:A 组无病变;B 组 1-9 个病变;或 C 组 10 个或更多病变。参与者完成了关于饮酒、吸烟和饮食史的生活方式调查。所有参与者在登记前均接受了喉咽镜检查;除了仅限于黏膜下层的浅表 SCC 患者外,仅纳入无头颈部癌症的患者。通过监测在食管和头颈部发现的病变被认为是同时发生的。研究终点是根据卢戈氏染色缺失病变的程度,内镜切除食管 SCC 后食管和头颈部同时发生 SCC 的累积发生率。在研究开始时,所有患者均被指示戒酒和戒烟。
在 2 年的研究期间,A 组患者中有 4%、B 组患者中有 9.4%、C 组患者中有 24.7%(P <.0001,A 组 vs B 组或 B 组 vs C 组)出现食管 SCC。A 组患者中无一例发生头颈部 SCC,B 组患者中有 1.7%、C 组患者中有 8.6%(P =.016,A 组 vs C 组和 P =.008,B 组 vs C 组)。A 组患者中有 4.0%、B 组患者中有 10.0%、C 组患者中有 31.4%(P <.0001,A 组 vs B 组或 A 组 vs C 组)发生食管或头颈部 SCC。戒酒可降低多发食管 SCC 的风险(调整后的危险比,0.47,95%置信区间,0.25-0.91;P =.025),而戒烟则没有。
食管内多个发育不良病变增加了多发 SCC 的风险。戒酒可降低同时发生 SCC 的风险。临床试验注册:UMIN000001676 和 UMIN000005466。